News articles from UVA Today.
Promising MS Drug Could Worsen Disease, UVA Research Suggests
Scientists at UVA urge more study before considering human testing of the small-molecule drug originally developed to fight cancer.
The Need for Speed: UVA Engineering Boosts Hypersonic Travel
Research into hypersonic travel is soaring again in the United States, and UVA Engineering is contributing historic expertise.
Repeated Small Blasts Put Military, Law Enforcement at Risk for Brain Injury
A UVA-led study examined specialists who use explosives to enter buildings, and found statistically significant differences in blood flow, brain structure and brain activity.
CNN's Dr. Sanjay Gupta Turns to UVA as Example of Wastewater Surveillance Testing
CNN's chief medical correspondent interviewed UVA's Dr. Amy Mathers about wastewater surveillance testing on his far-reaching podcast, "Coronavirus: Fact vs. Fiction."
COVID-19 Reveals How Obesity Harms the Body in Real Time, Not Just Over a Lifetime
Dr. Catherine Varney breaks down how obesity increases complications from COVID-19 infection and increases one's risk of getting infected in the first place.
UVA Unveils How HIV Begins to Invade Our Cells
A new method developed at the School of Medicine could boost efforts to prevent viral infections such as COVID-19.
Study: As Mid-Atlantic's Native Bee Populations Decline, an Exotic Species Proliferates
Bees, essential pollinators of plants and crops, are on the decline. Environmental scientists are seeking reasons.
Q&A: Professor Aims to Alleviate Teacher Burnout With Her New Book
Tish Jennings has answers for what she says has become an outdated educational system that causes stress and impairs teaching and learning.
Cancer's Dangerous Renovations to Our Chromosomes Revealed
New UVA research shows how cancer can remodel human chromosomes, affecting the workings of our genes and allowing cancer to spread.
COVID-19: Dexamethasone Discovery Carries Treatment Implications
Diabetes and other factors may reduce the lifesaving effectiveness of dexamethasone for patients with severe COVID-19, new research suggests.